Study Estimates 76 Percent of Brazilian City Exposed to SARS-CoV-2

The number, extrapolated from antibodies present in blood donors in Manaus, should be treated with caution, experts warn.

Written byIgnacio Amigo
| 6 min read
manaus brazil herd immunity covid-19 coronavirus pandemic sars-cov-2 blood bank donor antibody seroprevalence

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

ABOVE: © ISTOCK.COM, DANIEL FIGUERIEDO

In a study published in Science December 8, a group of researchers estimate that 76 percent of the population of Manaus, the first Brazilian city to be hard hit by the coronavirus pandemic, could have been infected with the SARS-CoV-2 virus so far, based on antibodies present in samples from blood banks. The report also estimates that in São Paulo, Brazil’s largest city, that percentage is much lower, accounting for 29 percent of the population. According to the paper, these results highlight the failure of Manaus to control the spread of the virus.

The findings are based on the analysis of samples from donor blood centers. Because Brazilian law establishes that blood banks should keep samples for six months, the researchers were able to go back in time and trace the unravelling of the pandemic between February and October. In the case of Manaus, they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies